“The European Fee in the present day (Friday) proposed to EU member states to purchase a further 200 million doses of COVID-19 vaccine produced by BioNTech-Pfizer, with the choice to buy one other 100 million of doses.

It will enable the EU to purchase a complete of 600 million doses of this vaccine, which is already used within the EU, “the assertion stated. Agerpres.

Von der Leyen stated a further 75 million doses of the vaccine can be delivered within the second quarter of this yr.

The EU government, which is negotiating on behalf of member states, has secured contracts for the supply of greater than 2 billion potential vaccines from six producers (together with AstraZeneca, the American Johnson & Johnson group, the Franco-British alliance Sanofi-GSK, the German firm CureVac and the American firm Moderna).

She is in negotiations with the Individuals at Novavax.
Solely two vaccines – from Pfizer-BioNTech and Moderna, on Wednesday – acquired the inexperienced gentle from the European Medicines Company (EMA), based on information.ro.
“By the 2 licensed vaccines, we’ve got secured a dose that enables us to vaccinate 380 million Europeans, ie 80% of the inhabitants, and different vaccines will observe within the coming weeks and months,” stated the president of the Fee.
The EU’s vaccine portfolio gives “2.3 billion doses of vaccine, which is greater than sufficient to vaccinate your complete inhabitants,” says Ursula von der Leyen.